Concepedia

Avivit Ochaion

AO

Statistics

Publications

16

Citations

1.4K

H-Index

15

Active since

2002

Affiliations

Can-Fite BioPharma (Israel)(Current)

Tel Aviv University

Rabin Medical Center

Bar-Ilan University

Temple University

Avivit Ochaion is an author at Can-Fite BioPharma (Israel) specializing in medicine, cell signaling, and immunology.

Top concepts

Publications per year

2002–2010

16

Publications

16

The A3 Adenosine Receptor Is Highly Expressed in Tumor <b> <i>versus</i> </b> Normal Cells

Lea Madi, Avivit Ochaion, Lea Rath‐Wolfson et al. · Clinical Cancer Research · 2004 · 189 citations · Full text

Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.

Michael H. Silverman, Vibeke Strand, Doron Markovits et al. · PubMed · 2008 · 132 citations

Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment

S. Bar‐Yehuda, Lea Rath‐Wolfson, Luis Del Valle et al. · Arthritis & Rheumatism · 2009 · 124 citations

The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease

Avivit Ochaion, S. Bar‐Yehuda, Shira Cohen et al. · Cellular Immunology · 2009 · 117 citations

, , +11

A3 Adenosine Receptor Activation in Melanoma Cells

Lea Madi, Sara Bar‐Yehuda, Faina Barer et al. · Journal of Biological Chemistry · 2003 · 100 citations · Full text

1–5 of 16